TTI-101 targets STAT3/c-Myc signaling pathway to suppress cervical cancer progression: an integrated experimental and computational analysis
TTI-101 exhibited anticancer effects by targeting the STAT3/c-Myc signaling pathway, inducing cell cycle arrest, and promoting apoptosis in CC cells. These findings provide valuable insights into the development of novel therapeutic strategies for cervical cancer. Further investigation is warranted to validate the clinical application of TTI-101.
Authors
- Yuyan Dong (ORCID: https://orcid.org/0009-0007-4916-1453)
- Yi Li (ORCID: https://orcid.org/0000-0001-8863-4240)
Institutions
- Shandong University (CN)
- Shandong Provincial Hospital (CN)
- Shandong Maternal and Child Health Hospital (CN)
Publication Details
- Journal
- Cancer Cell International
- Published
- 2024-08-12
- DOI
- https://doi.org/10.1186/s12935-024-03463-6
- Citations
- 5
- Primary Topic
- Cytokine Signaling Pathways and Interactions
- Type
- article
- Field-Weighted Citation Impact
- 1.41